New Faculty Q&A with Andrea Galmozzi, PhD

Andrea Galmozzi, PhDgalmozzi

Assistant Professor
Division of Endocrinology, Diabetes and Metabolism

What is your primary professional focus in any or all of our mission areas (clinical, research, and/or medical education)?
My primary focus is on research. In my laboratory, we study the transcriptional regulation that leads to metabolic adaptation of cells in response to environmental changes, with a specific focus on the adipose tissue. We use a broad toolkit, including “omics” technologies (proteomics, metabolomics and transcriptomics) cell and molecular biology, and animal models of disease to identify functional pathways amenable to pharmacological modulation that can provide new avenues to develop safer and more effective treatment for metabolic disorders, such as obesity and type 2 diabetes.

What drew you to UW-Madison and the Department of Medicine?
UW-Madison is an outstanding institution for diabetes research, with a longstanding history of seminal contributions to the field. The resources and collaborative environment of UW-Madison make a perfect habitat for newborn labs to bloom into solid research programs. Additionally, the possibility to interact with clinicians at the SMPH on a daily basis is a tremendous advantage that reminds you of the broader picture of the diseases that sometimes PhD researchers forget. 

What are you most excited about during your first year with the department in this role?
I look forward to doing great science and interacting with the incredible team of scientists we have all around us. Everyone here believes that science matters only when it is open and shared with others, and I am so excited about that.  

What do you enjoy doing when you’re not working?
Like every good Italian, I am a big soccer fan and food lover. A good pizza, watching Atalanta (my hometown team) with my family has no price. 

Favorite piece of advice from a mentor or inspiring figure in your life?
The best that can happen is to observe something you can’t explain (yet).

News Term